Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp has elevated Eric Powers to Chief Legal Officer and appointed Ronda Sheffield as Chief Human Resources Officer, Zachary Kobrin as General Counsel, and Aaron Lopez as Director of Government Affairs, effective March 15, 2021. These appointments aim to strengthen Trulieve's legal, HR, and government affairs capabilities to better support its national expansion strategy as a leading cannabis brand. With a focus on growth, the new leadership team is poised to enhance organizational effectiveness and compliance within the evolving cannabis industry.
Trulieve Cannabis Corp (OTC: TCNNF) has partnered with Morehouse School of Medicine to advance cannabis research and education. This collaboration will focus on medical cannabis-related research, including a real-world data registry and cannabinoid receptor genetics. Trulieve aims to develop personalized medical cannabis treatments, employee career fairs, and educational offerings. The partnership marks a significant step in understanding cannabis’s potential and effectiveness in medical applications.
Trulieve Cannabis Corp. (OTCQX: TCNNF) has opened two new dispensaries in Central Florida, located in Clearwater and Tampa, marking its 81st and 82nd locations nationwide. These dispensaries provide access to Florida's largest range of medical cannabis products, enhancing patient accessibility. Trulieve now operates 77 dispensaries in Florida. To celebrate the openings, a one-day 25% discount is available for all patients. The company emphasizes safety measures in compliance with health guidelines and has witnessed a growing patient registry nearing 500,000 in Florida.
On February 26, 2021, Trulieve Cannabis Corp (OTC: TCNNF) announced a partnership with the Thurgood Marshall College Fund (TMCF), committing $20,000 for scholarships and $15,000 for internship support. This initiative aims to enhance diversity, equity, and inclusion by providing opportunities for students at Historically Black Colleges and Universities. CEO Kim Rivers emphasized Trulieve's commitment to educational equity, while TMCF expressed gratitude for the support aimed at reducing financial barriers for students pursuing higher education.
Trulieve Cannabis Corp. has opened its 80th dispensary nationwide, marking its 75th location in Florida and its first in Tamarac. This new outlet expands patient access to Florida's largest selection of medical cannabis products. CEO Kim Rivers emphasized the company's commitment to patient care. For the grand opening on February 27, 2021, a 25% in-store discount is offered. Trulieve is a key player in the state's cannabis market, consistently selling approximately half of Florida's medical marijuana volume. The firm operates across multiple states and focuses on a 'seed-to-sale' model.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced CEO Kim Rivers will speak at the Benzinga Cannabis Capital Conference on February 25, 2021, at 3:05 p.m. EST. The event will feature top executives and investors in the cannabis industry. As a leading medical cannabis company, Trulieve operates as a vertically integrated "seed-to-sale" organization, primarily in Florida, and also has a presence in California, Massachusetts, and Connecticut. Trulieve is recognized for cultivating and producing cannabis products in-house and distributing them through its own dispensaries.
Trulieve Cannabis Corp. has announced the opening of its 79th dispensary in Jacksonville, Florida, marking its third location in the area. This new outlet expands patient access to Florida's largest inventory of medical cannabis products, supporting the company's goal of ensuring direct access across the state. With a 25% discount available on opening day for all patients, Trulieve continues to cater to the growing patient base, now exceeding 475,000 registered medical marijuana patients. The company emphasizes safety measures in-store and offers virtual consultations for product guidance.
Trulieve Cannabis Corp. expands its product lineup with the launch of Cold Cure Live Rosin, a premium solventless cannabis extract, in Florida. This product offers enhanced terpene profiles and full-spectrum relief for patients. Cold Cure Live Rosin utilizes ice water extraction techniques, preserving the natural flavors and effects of cannabis. The initial batches will be available in select stores starting February 4, 2021, with plans for statewide availability. The company continues to strengthen its position as a leading cannabis provider, growing its portfolio of high-quality offerings.
Trulieve Cannabis Corp. has announced the launch of the Cultivar Collection, featuring premium, small-batch cannabis strains cultivated by master growers. This collection will be available at select stores in Florida starting October 17th. The initial strains include Grape Cake, Sunset Sherbet x Kush Mints, and Rae Bae, each designed for unique flavor and terpene profiles. Trulieve's commitment to innovation aims to provide an elevated experience for its patients.
Trulieve Cannabis Corp. CEO Kim Rivers will speak on October 15, 2020, at 3:15 PM EDT during the Benzinga Cannabis Capital Conference. This virtual event will showcase interactive presentations from top CEOs and investors in the cannabis sector. The discussion, moderated by Zack Guzman from Yahoo! Finance, will focus on the regulatory landscape affecting multi-state operators (MSOs). Trulieve is a leading medical cannabis company based in Florida, operating in multiple states, including California, Massachusetts, and Connecticut. Learn more about the conference and register online.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
